Time to Cardioversion for Acute Atrial Fibrillation and Thromboembolic Complications

被引:136
|
作者
Nuotio, Ilpo [1 ]
Hartikainen, Juha E. K. [2 ]
Gronberg, Toni [3 ]
Biancari, Fausto [4 ]
Airaksinen, K. E. Juhani [3 ]
机构
[1] Turku Univ Hosp, Div Med, Turku 20521, Finland
[2] Kuopio Univ Hosp, Ctr Heart, SF-70210 Kuopio, Finland
[3] Turku Univ Hosp, Ctr Heart, Turku 20521, Finland
[4] Oulu Univ Hosp, Dept Surg, Oulu, Finland
来源
关键词
D O I
10.1001/jama.2014.3824
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
下载
收藏
页码:647 / 649
页数:3
相关论文
共 50 条
  • [31] Thromboembolic events following cardioversion of acute atrial fibrillation and flutter: a systematic review and meta-analysis
    Brenton M. Wong
    Jeffrey J. Perry
    Wei Cheng
    Bo Zheng
    Kevin Guo
    Monica Taljaard
    Allan C. Skanes
    Ian G. Stiell
    Canadian Journal of Emergency Medicine, 2021, 23 : 500 - 511
  • [32] Thromboembolic events following cardioversion of acute atrial fibrillation and flutter: a systematic review and meta-analysis
    Wong, Brenton M.
    Perry, Jeffrey J.
    Cheng, Wei
    Zheng, Bo
    Guo, Kevin
    Taljaard, Monica
    Skanes, Allan C.
    Stiell, Ian G.
    CANADIAN JOURNAL OF EMERGENCY MEDICINE, 2021, 23 (04) : 500 - 511
  • [33] Reversal of atrial stunning following cardioversion of atrial arrhythmia: Implications for the prevention of thromboembolic complications
    Sanders, P
    Morton, JB
    Morgan, JG
    Kalman, JM
    Vohra, JK
    Davidson, NC
    Spence, S
    Sparks, PB
    CIRCULATION, 2001, 104 (17) : 331 - 331
  • [34] The time of cardioversion in patients with hyperthyroidism and atrial fibrillation
    Ary, H.
    Erdogan, E.
    Koca, V.
    Bozat, T.
    CIRCULATION, 2008, 118 (12) : E235 - E235
  • [35] Strategies for cardioversion of atrial fibrillation - Time for a change?
    Silverman, DI
    Manning, WJ
    NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (19): : 1468 - 1470
  • [36] Thromboembolic events around the time of cardioversion for atrial fibrillation in patients receiving antiplatelet treatment in the ACTIVE trials
    McIntyre, William F.
    Connolly, Stuart J.
    Wang, Jia
    Masiero, Simona
    Benz, Alexander P.
    Conen, David
    Wong, Jorge A.
    Beresh, Heather
    Healey, Jeff S.
    EUROPEAN HEART JOURNAL, 2019, 40 (36) : 3026 - 3032
  • [37] TRANSESOPHAGEAL ECHOCARDIOGRAPHY BEFORE AND DURING DIRECT-CURRENT CARDIOVERSION OF ATRIAL-FIBRILLATION - EVIDENCE FOR ATRIAL STUNNING AS A MECHANISM OF THROMBOEMBOLIC COMPLICATIONS
    FATKIN, D
    KUCHAR, DL
    THORBURN, CW
    FENELEY, MP
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1994, 23 (02) : 307 - 316
  • [38] Rivaroxaban in the prevention of thromboembolic complications in patients with atrial fibrillation
    Gilyarov, M. Yu.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2012, 8 (03) : 453 - 456
  • [39] The risk factors of thromboembolic complications in patients with atrial fibrillation
    Zubilewicz, Renata
    Dziurzynska, Magdalena
    Jaroszynski, Andrzej
    FAMILY MEDICINE AND PRIMARY CARE REVIEW, 2013, 15 (01): : 46 - 49
  • [40] Current views on the prevention of thromboembolic complications in atrial fibrillation
    Bociek, Arkadiusz
    Manka, Ewa
    Bociek, Martyna
    Gmyrek, Joanna
    Sieron, Aleksander Romuald
    ACTA ANGIOLOGICA, 2018, 24 (02): : 44 - 50